Cargando…

Synergistic Immunity and Protection in Mice by Co-Immunization with DNA Vaccines Encoding the Spike Protein and Other Structural Proteins of SARS-CoV-2

The emergence of new variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has generated recurring worldwide infection outbreaks. These highly mutated variants reduce the effectiveness of current coronavirus disease 2019 (COVID-19) vaccines, which are designed to target only the s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Jinni, Huang, Baoying, Deng, Yao, Wang, Wen, Zhai, Chengcheng, Han, Di, Wang, Na, Zhao, Ying, Zhai, Desheng, Tan, Wenjie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967269/ https://www.ncbi.nlm.nih.gov/pubmed/36851120 http://dx.doi.org/10.3390/vaccines11020243

Ejemplares similares

DNA Vaccines Expressing the Envelope and Membrane Proteins Provide Partial Protection Against SARS-CoV-2 in Mice
por: Chen, Jinni, et al.
Publicado: (2022)

Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus
por: Deng, Yao, et al.
Publicado: (2018)

Single-Dose Intranasal Immunisation with Novel Chimeric H1N1 Expressing the Receptor-Binding Domain of SARS-CoV-2 Induces Robust Mucosal Immunity, Tissue-Resident Memory T Cells, and Heterologous Protection in Mice
por: Wang, Donghong, et al.
Publicado: (2023)

Sublingual immunization with recombinant adenovirus encoding SARS-CoV spike protein induces systemic and mucosal immunity without redirection of the virus to the brain
por: Shim, Byoung-Shik, et al.
Publicado: (2012)

A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein
por: Chen, Yingzhu, et al.
Publicado: (2017)

A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein
por: Chen, Yingzhu, et al.
Publicado: (2017)

Control of SARS-CoV-2 infection after Spike DNA or Spike DNA+Protein co-immunization in rhesus macaques
por: Rosati, Margherita, et al.
Publicado: (2021)

Mutations of SARS-CoV-2 spike protein: Implications on immune evasion and vaccine-induced immunity
por: Mengist, Hylemariam Mihiretie, et al.
Publicado: (2021)

Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model
por: Du, Lanying, et al.
Publicado: (2007)

Immune response and protective efficacy of the SARS-CoV-2 recombinant spike protein vaccine S-268019-b in mice
por: Homma, Tomoyuki, et al.
Publicado: (2022)

SARS-CoV-2 Spike Protein Interacts with Multiple Innate Immune Receptors
por: Gao, Chao, et al.
Publicado: (2020)

Enhanced protective immunity against SARS-CoV-2 elicited by a VSV vector expressing a chimeric spike protein
por: Li, Hongyue, et al.
Publicado: (2021)

The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection
por: Jiaming, Lan, et al.
Publicado: (2017)

A DNA Vaccine Encoding the Full-Length Spike Protein of Beta Variant (B.1.351) Elicited Broader Cross-Reactive Immune Responses against Other SARS-CoV-2 Variants
por: Zhao, Gan, et al.
Publicado: (2023)

A recombinant spike protein subunit vaccine confers protective immunity against SARS-CoV-2 infection and transmission in hamsters
por: Wu, Yangtao, et al.
Publicado: (2021)

Optimization of SARS-CoV-2 Spike Protein Expression in the Silkworm and Induction of Efficient Protective Immunity by Inoculation With Alum Adjuvants
por: Masuda, Akitsu, et al.
Publicado: (2022)

Spike protein of SARS-CoV-2 Omicron variant: An in-silico study evaluating spike interactions and immune evasion
por: Jimenez Ruiz, Jose A., et al.
Publicado: (2022)

Co-expression of Interleukin-15 Enhances the Protective Immune Responses Induced by Immunization with a Murine Malaria MVA-Based Vaccine Encoding the Circumsporozoite Protein
por: Parra, Marcela, et al.
Publicado: (2015)

Co-Immunization With CHIKV VLP and DNA Vaccines Induces a Promising Humoral Response in Mice
por: Zhao, Zhimin, et al.
Publicado: (2021)

Analysis of the SARS-CoV-2 spike protein glycan shield: implications for immune recognition
por: Grant, Oliver C., et al.
Publicado: (2020)

Molecular switches regulating the potency and immune evasiveness of SARS-CoV-2 spike protein
por: Wan, Yushun, et al.
Publicado: (2021)

Immune Epitopes of SARS-CoV-2 Spike Protein and Considerations for Universal Vaccine Development
por: Magazine, Nicholas, et al.
Publicado: (2023)

Intranasal immunization with avian paramyxovirus type 3 expressing SARS-CoV-2 spike protein protects hamsters against SARS-CoV-2
por: Park, Hong-Su, et al.
Publicado: (2022)

Characterization of humoral responses in mice immunized with plasmid DNAs encoding SARS-CoV spike gene fragments
por: Zeng, Fanya, et al.
Publicado: (2004)

DNA vaccine candidate encoding SARS-CoV-2 spike proteins elicited potent humoral and Th1 cell-mediated immune responses in mice
por: Prompetchara, Eakachai, et al.
Publicado: (2021)

A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses
por: Sun, Weina, et al.
Publicado: (2021)

Optimized intramuscular immunization with VSV-vectored spike protein triggers a superior immune response to SARS-CoV-2
por: Taddeo, Adriano, et al.
Publicado: (2022)

Robust Immunity and Heterologous Protection against Influenza in Mice Elicited by a Novel Recombinant NP-M2e Fusion Protein Expressed in E. coli
por: Wang, Wenling, et al.
Publicado: (2012)

Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognition
por: Grant, Oliver C., et al.
Publicado: (2020)

SARS-CoV-2 deregulates the vascular and immune functions of brain pericytes via Spike protein
por: Khaddaj-Mallat, Rayan, et al.
Publicado: (2021)

A plant-produced SARS-CoV-2 spike protein elicits heterologous immunity in hamsters
por: Margolin, Emmanuel, et al.
Publicado: (2023)

Adenovirus Vaccine Containing Truncated SARS-CoV-2 Spike Protein S1 Subunit Leads to a Specific Immune Response in Mice
por: Chen, Keda, et al.
Publicado: (2023)

Rational Design of Synergistic Structure Between Single-Atoms and Nanoparticles for CO(2) Hydrogenation to Formate Under Ambient Conditions
por: Zhai, Shengliang, et al.
Publicado: (2022)

Lack of antibody-mediated cross-protection between SARS-CoV-2 and SARS-CoV infections
por: Yang, Ren, et al.
Publicado: (2020)

Oral immunization with a novel attenuated Salmonella Gallinarum encoding infectious bronchitis virus spike protein induces protective immune responses against fowl typhoid and infectious bronchitis in chickens
por: Hajam, Irshad Ahmed, et al.
Publicado: (2018)

SARS-CoV-2 Spike Protein Vaccine-Induced Immune Imprinting Reduces Nucleocapsid Protein Antibody Response in SARS-CoV-2 Infection
por: Delgado, Juan F., et al.
Publicado: (2022)

Intranasal immunization with plasmid DNA encoding spike protein of SARS-coronavirus/polyethylenimine nanoparticles elicits antigen-specific humoral and cellular immune responses
por: Shim, Byoung-Shik, et al.
Publicado: (2010)

A Vaccine of SARS-CoV-2 S Protein RBD Induces Protective Immunity
por: Qu, Qiaoqiao, et al.
Publicado: (2022)

In silico binding profile characterization of SARS-CoV-2 spike protein and its mutants bound to human ACE2 receptor
por: Zhang, Yuzhao, et al.
Publicado: (2021)

SARS-CoV-2-specific T cell immunity to structural proteins in inactivated COVID-19 vaccine recipients
por: Deng, Yao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a27qc39cujtn3dbqri0gl1vhp7